An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis. - Yamashita, Takashi; Lakota, Katja; Taniguchi, Takashi; Yoshizaki, Ayumi; Sato, Shinichi; Hong, Wen; Zhou, Xingchun; Sodin-Semrl, Snezn; Fang, Feng; Asano, Yoshihide; Varga, John (Scientific Reports, 2018)